Astra clarifies pipeline strategy
https://www.reuters.com/article/companyNews/idUKLNE55207A20090603?symbol=AZN.L&sp=true
Again not saying anything about what they will buy next...
CEO gives industry forecast
Brennan prefers collaborations to acquisitions and expects alliances to be a growing theme across the industry.
In addition to conventional licensing and partnership deals, hepredicted more joint clinical trials, particularly in cancer, along thelines of the pioneering tie-up with Merck & Co (MRK.N) on two early-stage cancer drugs signed this week.
"There will be pressure from the medical community for us to do more (joint trials) and for others to copy," he said.
Any deal, take over, collaboration, parnership, licensing would pump this stock to the next level.
Strategic Review is still open.
Much much less riskier play today.
Those who are selling didn't "get it".